Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
نویسندگان
چکیده
A 69 year old previously healthy man was admitted with a 40 minute history of chest pain. The electrocardiograph showed evidence of an acute anterolateral myocardial infarction (MI). He was treated with soluble aspirin (300 mg), heparin (5000 units bolus), alteplase (rtPA) (100 mg), and heparin infusion (1000 units/h). An hour and 50 minutes later he complained of a dry mouth and examination showed considerable swelling and discolouration of the tongue and floor of the mouth, with the tongue occupying about 75% of the oral cavity. The appearances were consistent with
منابع مشابه
Lingual Haematoma due to Tenecteplase in a Patient with Acute Myocardial Infarction
The use of intravenous thrombolytic agents has revolutionised the treatment of acute myocardial infarction. However, the improvement in mortality rate achieved with these drugs is tempered by the risk of serious bleeding complications, including intracranial haemorrhage. Tenecteplase is a genetically engineered mutant tissue plasminogen activator. Haemorrhagic complications of tissue plasminoge...
متن کاملLingual angioedema with macroglossia during the treatment of acute ischemic stroke with alteplase
Alteplase (recombinant tissue plasminogen activator) has been used in the treatment of acute ischemic stroke for 10 years. The application of this drug is considered safe and effective. However, alteplase is also associated with side effects. The author is reporting on an unusual side effect of angioedema that is triggered by alteplase. Angioedema occurs through alteplase according to this stud...
متن کاملStaphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?
T HROMBOTIC COMPLICATIONS of cardiovascular disease are a main cause of death and disability and, consequently, thrombolysis could favorably influence the outcome of such life-threatening diseases as myocardial infarction, cerebrovascular thrombosis, and venous thromboembolism. Thrombolytic agents are plasminogen activators that convert plasminogen, the inactive proenzyme of the fibrinolytic sy...
متن کاملRapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.
Alteplase (recombinant tissue-type plasminogen activator (rt-PA)) was infused within four hours of onset of symptoms in 286 patients with acute myocardial infarction. Delayed coronary angiography was performed 72 hours after admission with coronary angioplasty if indicated. Electrocardiographic monitoring was continuous during the first hour of treatment. The sum of the ST segment elevations (s...
متن کاملTissue Plasminogen Activator in Rabbit Models of Embolic Stroke and Peripheral Bleeding
8. Stump DC, Califf RM, Topol EJ, Sigmon K, Thornton D, Masek R, Anderson L, Collen D, and the TAMI Study Group. Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator: correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. Circulation.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Heart
دوره 75 4 شماره
صفحات -
تاریخ انتشار 1995